1. DSpace at Nirma University
  2. 04. Institute of Pharmacy
  3. B. Pharm Project Reports
Please use this identifier to cite or link to this item: http://10.1.7.192:80/jspui/handle/123456789/9827
Full metadata record
DC FieldValueLanguage
dc.contributor.authorShah, Shivani Manoj-
dc.contributor.authorParmar, Devarsh Bharatkumar-
dc.contributor.authorParmar, Harshil Navinbhai-
dc.contributor.authorMakwana, Rohit Batukbhai-
dc.date.accessioned2021-07-27T06:58:46Z-
dc.date.available2021-07-27T06:58:46Z-
dc.date.issued2021-05-
dc.identifier.urihttp://10.1.7.192:80/jspui/handle/123456789/9827-
dc.description.abstractCovid-19 originated from China and spread throughout the world. Many people get infected to this virus. People have severe, moderate to mild symptoms. People with severe symptoms were admitted to hospitals and treated with medications like Remdesivir and Favipiravir. Remdesivir is used to decrease the viral load. Where convalescent plasma therapy is used to boost the immune system. Person who has mild symptoms were isolated in home with necessary precautions.en_US
dc.publisherInstitute of Pharmacy, Nirma University, A'baden_US
dc.relation.ispartofseriesPPR01043;-
dc.subjectPPR01043en_US
dc.subjectB. Pharm Project Reporten_US
dc.subjectPharmaceutical Chemistryen_US
dc.subject17BPH012en_US
dc.subject17BPH082en_US
dc.subject17BPH093en_US
dc.subject18BPH133en_US
dc.subjectCovid-19en_US
dc.subjectRemdesiviren_US
dc.subjectFavipiraviren_US
dc.titleA Review on Drugs Used in COVID-19en_US
dc.typeProject Reporten_US
Appears in Collections:B. Pharm Project Reports

Files in This Item:
File Description SizeFormat 
PPR01043.pdfPPR010432.14 MBAdobe PDFThumbnail
View/Open
Show simple item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.